Germany
Japan
United Kingdom
China
USD 494.00
In Stock
Autoimmunity
View as table Download
USD 494.00
In Stock
ST2 biotinylated detection Mouse Monoclonal antibody, clone OTI21A7
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Biotin |
| Matched ELISA Pair | TA600553 |
USD 494.00
In Stock
IL-6 Capture Mouse Monoclonal antibody, clone OTI7D8
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Matched ELISA Pair | TA700552 |
ST2 Capture Mouse Monoclonal antibody, clone OTI6E12
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Matched ELISA Pair | TA700553 |
USD 494.00
2 Weeks
IL-6 Biotinylated detection Mouse Monoclonal antibody, clone OTI1D9
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Biotin |
| Matched ELISA Pair | TA600552 |
USD 458.00
In Stock
USD 494.00
2 Weeks
purified ESR1 biotinylated mouse monoclonal detection antibody, validated for Luminex assays
| Applications | ELISA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Biotin |
| Matched ELISA Pair | TA600545 |
USD 494.00
2 Weeks
purified ESR1 biotinylated mouse monoclonal detection antibody, validated for Luminex assays
| Applications | ELISA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Biotin |
| Matched ELISA Pair | TA600545 |
USD 494.00
2 Weeks
purified ESR1 biotinylated mouse monoclonal detection antibody, validated for Luminex assays
| Applications | ELISA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Biotin |
| Matched ELISA Pair | TA600545 |
Active filters
Reactivities
- Human
Assay Platforms
- 96-well plate
Families
- Druggable Genome
Filter by
Category
Target Symbol
Applications
Antibody Hosts
Clonalities
Conjugates
Assay Types
Pathways
- Cytokine-cytokine receptor interaction (6)
- Graft-versus-host disease (6)
- Hematopoietic cell lineage (6)
- Hypertrophic cardiomyopathy (HCM) (6)
- NOD-like receptor signaling pathway (6)
- Toll-like receptor signaling pathway (6)
- Cytosolic DNA-sensing pathway (4)
- Jak-STAT signaling pathway (4)
- Pathways in cancer (4)
- Prion diseases (4)
- Adipocytokine signaling pathway (2)
- Allograft rejection (2)
- Alzheimer's disease (2)
- Amyotrophic lateral sclerosis (ALS) (2)
- Apoptosis (2)
- Asthma (2)
- Dilated cardiomyopathy (2)
- Fc epsilon RI signaling pathway (2)
- MAPK signaling pathway (2)
- Natural killer cell mediated cytotoxicity (2)
- RIG-I-like receptor signaling pathway (2)
- Systemic lupus erythematosus (2)
- T cell receptor signaling pathway (2)
- TGF-beta signaling pathway (2)
- Type I diabetes mellitus (2)
- Type II diabetes mellitus (2)